Physician profile
Jason Crespo
NPI 1790123487
$8,272.99
in general payments reported to CMS, 2019-2025
24 companies · $3,496 in 2025
The $3,496 reported for 2025 was more than what 90% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,891 · 2020: $171 · 2021: $77.64 · 2022: $45.08 · 2023: $1,335 · 2024: $1,258 · 2025: $3,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,022 · Travel and Lodging: $2,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,021.64 |
| Travel and Lodging | $2,067.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,112.44 | 2019-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Stryker Corporation | $1,797.67 | 2019-2025 | Spy-Phi System, Na |
| Medical Device Business Services, INC. | $915.97 | 2023 | |
| Mentor Worldwide LLC | $895.20 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $630.60 | 2023-2024 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Integra Lifesciences Corporation | $443.70 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Organogenesis INC. | $340.13 | 2024-2025 | Puraply Wound Matrix, Puraply Franchise, Affinity |
| Polynovo North America LLC | $220.32 | 2025 | Novosorb Btm |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Endo Pharmaceuticals INC. | $111.22 | 2019 | |
| Solventum Corporation | $109.12 | 2024 | Kerramax Care, Activ.A.C., V.A.C. Veraflo |
| Ethicon US, LLC | $103.58 | 2025 | Ethicon, Vistaseal |
| Endomagnetics LTD | $70.48 | 2023 | Magseed, Magtrace |
| Innovation Technologies INC | $68.43 | 2022-2024 | Irrisept |
| Musculoskeletal Transplant Foundation INC. | $54.66 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $42.93 | 2020-2021 | |
| Motiva USA, LLC | $38.76 | 2024 | |
| Galderma Laboratories, L.P. | $36.98 | 2021 | |
| Lilly USA, LLC | $32.11 | 2022 | |
| Kerecis Limited | $22.52 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Electronic Waveform Lab, INC. | $20.63 | 2019 | |
| Smith+Nephew, INC. | $20.23 | 2023 | Collagenase Santyl |
| Arthrex, INC. | $18.55 | 2021 | |
| Baxter Healthcare | $16.76 | 2023 | Tisseel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Crespo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.